PCM
ARNA

Prelude Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Prelude Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,270
Closed -$79K – 2276
2014
Q4 		$79K Buy
+2,270
New +$92.2K 0.01% 1094

Prelude Capital Management's ARNA Position: Q1 2022 in Review

Prelude Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 4,532 shares — an estimated $421K sold.

Prelude Capital Management first reported a position in ARNA in Q4 2015 and held it in 11 quarters. The position peaked at $421K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Prelude Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Prelude Capital Management sold 4,532 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $421K.
  • Prelude Capital Management first reported a position in Arena Pharmaceuticals Inc in Q4 2015 and held it in 11 quarters.
  • Prelude Capital Management's Arena Pharmaceuticals Inc position peaked at $421K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Prelude Capital Management's 13F filing for Q1 2022, filed 16 May 2022.